FDA NEWS

FDA delays decision on Eli Lilly blood clot drug - NWITimes.com
INDIANAPOLIS - Eli Lilly shares hit a new 52-week low Tuesday, a day after the company announced the Food and Drug Administration needed three more months to review its blood thinner drug. The FDA did not ask for new clinical trials, but company
Source: nwitimes.com

India's Ranbaxy gets FDA nod for Valcyte generic - Reuters
MUMBAI, June 25 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO: Quote , Profile , Research , Stock Buzz ) said it had received tentative approval from the U.S. Food and Drug Administration for the generic version of Roche's (ROG.VX: Quote
Source: www.reuters.com

Microchips may be hazards in hospitals - Philadelphia Inquirer
CHICAGO - Wireless systems used by many hospitals to keep track of medical equipment can cause potentially deadly breakdowns in life-saving devices such as breathing and dialysis machines, researchers reported yesterday in a study that warned
Source: www.philly.com

Ranbaxy gets US FDA nod for Valcyte generic - Livemint.com
Mumbai: India’s Ranbaxy Laboratories Ltd has received tentative approval from the US Food and Drug Administration for the generic version of Roche’s anti-viral Valcyte, saying it believed it was the first to file. Ranbaxy said it had tentative
Source: www.livemint.com

Tomatoes pulled from local shelves, menus - Glendale News-Press
GLENDALE — Several local restaurants and grocery stores have cut Roma, plum and red round tomatoes from their food supplies, heeding the Food and Drug Administration’s national warnings that the tomatoes were linked to a salmonella outbreak. The
Source: www.glendalenewspress.com

FDA delays decision on Eli Lilly blood clot drug prasugrel by 3 months - International Herald Tribune
INDIANAPOLIS : Eli Lilly shares hit a new 52-week low Tuesday, a day after the company announced the Food and Drug Administration needed three more months to review its blood thinner drug. The FDA did not ask for new clinical trials, but company
Source: www.iht.com

GlaxoSmithKline says FDA approves KINRIX combination vaccine for - CNBC
PHILADELPHIA (Thomson Financial) - GlaxoSmithKline said the U.S. Food and Drug Administration (FDA) has approved KINRIX, a combination vaccine for children against diphtheria, tetanus, pertussis and polio diseases. Clinical studies of KINRIX have
Source: www.cnbc.com